|
US4838925A
(en)
|
1986-04-25 |
1989-06-13 |
E. I. Du Pont De Nemours And Company |
Heterocyclic acyl sulfonamides
|
|
JP3763997B2
(ja)
|
1999-05-13 |
2006-04-05 |
富士写真フイルム株式会社 |
感熱記録材料
|
|
JP4331823B2
(ja)
|
1999-05-21 |
2009-09-16 |
富士フイルム株式会社 |
ピロロ［１，２−ａ］−１，３，５−トリアジン−４−オン系化合物
|
|
CZ20022332A3
(cs)
|
2000-01-07 |
2003-01-15 |
Transform Pharmaceuticals, Inc. |
Sestava vzorků
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
JP4070966B2
(ja)
|
2001-06-28 |
2008-04-02 |
株式会社カネボウ化粧品 |
新規ガラクトシルセラミド類縁体及び用途
|
|
MXPA04002495A
(es)
|
2001-10-22 |
2004-05-31 |
Pfizer |
Compuestos de imidazopiridin como moduladores del receptor 5-ht4.
|
|
KR20040087335A
(ko)
|
2002-03-01 |
2004-10-13 |
야마노우치세이야쿠 가부시키가이샤 |
질소 함유 복소환 화합물
|
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
|
BR0314584A
(pt)
|
2002-09-20 |
2005-08-09 |
Pfizer |
Compostos piperidinil-imidazopiridina n-substituìda como moduladores e receptores 5-ht4
|
|
US7550470B2
(en)
|
2002-12-11 |
2009-06-23 |
Merck & Co. Inc. |
Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
|
|
JP2004277337A
(ja)
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
CA2523077A1
(en)
|
2003-04-21 |
2004-11-04 |
Pfizer Inc. |
Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
|
|
EP1682504B1
(en)
|
2003-11-12 |
2012-12-26 |
Amicus Therapeutics Inc. |
Hydroxy piperidine derivatives to treat gaucher disease
|
|
GB0329214D0
(en)
*
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
CA2556404A1
(en)
|
2004-02-18 |
2005-08-25 |
Banyu Pharmaceutical Co., Ltd. |
Nitrogenous fused heteroaromatic ring derivative
|
|
EP1753422B1
(en)
|
2004-05-14 |
2008-05-28 |
The Cleveland Clinic Foundation |
Small molecule inhibitors for mrp1 and other multidrug transporters
|
|
ES2299044T3
(es)
|
2004-06-21 |
2008-05-16 |
F. Hoffmann-La Roche Ag |
Derivados de pirrazol-pirimidina.
|
|
CA2568850A1
(en)
|
2004-08-02 |
2006-02-16 |
Schwarz Pharma Ag |
Indolizine carboxamides and the aza and diaza derivatives thereof
|
|
DE102004049363A1
(de)
|
2004-10-08 |
2006-04-13 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
AU2006206573B9
(en)
|
2005-01-19 |
2011-09-29 |
Merck Sharp & Dohme Corp. |
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
KR100968291B1
(ko)
|
2005-02-11 |
2010-07-07 |
에프. 호프만-라 로슈 아게 |
Ｍｇｌｕｒ２ 길항제로서의 피라졸로-피리미딘 유도체
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
WO2006115168A1
(ja)
|
2005-04-21 |
2006-11-02 |
Dainippon Sumitomo Pharma Co., Ltd. |
Ｎ－置換フェニルアセトアミド誘導体およびそれを含有する医薬組成物
|
|
WO2006118256A1
(ja)
|
2005-04-28 |
2006-11-09 |
Kyowa Hakko Kogyo Co., Ltd. |
2-アミノキナゾリン誘導体
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
AR057979A1
(es)
|
2005-10-06 |
2008-01-09 |
Schering Corp |
PIRAZOLPIRIMIDINAS COMO INHIBIDORAS DE PROTEíNA QUINASA. COMPOSICIONES FARMACEUTICAS.
|
|
CA2626742A1
(en)
|
2005-10-21 |
2007-04-26 |
Exelixis, Inc. |
Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
|
|
CA2629743A1
(en)
|
2005-12-08 |
2007-06-14 |
Novartis Ag |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors
|
|
TW200800997A
(en)
*
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
ATE555788T1
(de)
|
2006-06-23 |
2012-05-15 |
Amicus Therapeutics Inc |
Verfahren zur behandlung neurologischer erkrankungen mittels verstärkung der beta - glucocerebrosidaseaktivität
|
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
|
WO2008019363A2
(en)
|
2006-08-07 |
2008-02-14 |
Albany Molecular Research, Inc. |
2-alkylbenzoxazole carboxamides as 5ht3 modulators
|
|
AU2007321924A1
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
US20080221092A1
(en)
|
2006-11-20 |
2008-09-11 |
Harald Bluhm |
Heterobicyclic metalloprotease inhibitors
|
|
EP2137187A1
(en)
|
2007-03-28 |
2009-12-30 |
Inovacia AB |
Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
EP2170842A1
(en)
|
2007-06-21 |
2010-04-07 |
Irm, Llc |
Protein kinase inhibitors and methods for using thereof
|
|
WO2009060835A1
(ja)
|
2007-11-05 |
2009-05-14 |
Kyoto University |
新規ユビキリン結合性小分子
|
|
WO2009060197A1
(en)
|
2007-11-08 |
2009-05-14 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazopyridazines for use as protein kinase inhibitors
|
|
WO2009070567A1
(en)
|
2007-11-28 |
2009-06-04 |
Schering Corporation |
2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
EP2240488B1
(en)
|
2008-02-06 |
2016-11-02 |
Bristol-Myers Squibb Company |
Substituted imidazopyridazines useful as kinase inhibitors
|
|
WO2009119088A1
(ja)
|
2008-03-25 |
2009-10-01 |
武田薬品工業株式会社 |
複素環化合物
|
|
CN102083438B
(zh)
|
2008-05-01 |
2016-11-09 |
西特里斯药业公司 |
作为沉默信息调节因子的调节剂的喹啉和相关类似物
|
|
EA201100613A1
(ru)
|
2008-10-14 |
2011-12-30 |
Астразенека Аб |
Конденсированные, спироциклические гетероароматические соединения для лечения бактериальных инфекций
|
|
SG194397A1
(en)
*
|
2008-10-31 |
2013-11-29 |
Genentech Inc |
Pyrazolopyrimidine jak inhibitor compounds and methods
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
ES2709108T3
(es)
|
2009-08-17 |
2019-04-15 |
Intellikine Llc |
Compuestos heterocíclicos y usos de los mismos
|
|
JP5985473B2
(ja)
*
|
2010-07-13 |
2016-09-06 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ＩＲＡＫ４モジュレーターとしてのピラゾロ［１，５ａ］ピリミジン及びチエノ［３，２ｂ］ピリミジン誘導体
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
TW201217312A
(en)
|
2010-09-22 |
2012-05-01 |
Gruenenthal Gmbh |
Substituted benzamide compounds
|
|
WO2012075393A2
(en)
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
|
PT3366688T
(pt)
*
|
2010-12-08 |
2022-05-11 |
Us Health |
Pirazolopirimidinas substituídas como ativadores de glucocerebrosidase
|
|
US9127000B2
(en)
|
2011-02-23 |
2015-09-08 |
Intellikine, LLC. |
Heterocyclic compounds and uses thereof
|
|
WO2012129258A1
(en)
*
|
2011-03-22 |
2012-09-27 |
Merck Sharp & Dohme Corp. |
Amidopyrazole inhibitors of interleukin receptor-associated kinases
|
|
CN103764166B
(zh)
|
2011-06-22 |
2017-10-24 |
通用医疗公司 |
蛋白质病的治疗
|
|
DK2746265T3
(da)
|
2011-08-18 |
2016-02-01 |
Nippon Shinyaku Co Ltd |
Heterocyclisk derivat som mikrosomal prostaglandin-E-syntase-(mPGEs)-inhibitor
|
|
CA2847075A1
(en)
|
2011-09-02 |
2013-03-07 |
Bayer Intellectual Property Gmbh |
Substituted annellated pyrimidine and the use thereof
|
|
US8961959B2
(en)
|
2011-10-17 |
2015-02-24 |
The Regents Of The University Of Michigan |
Glucosylceramide synthase inhibitors and therapeutic methods using the same
|
|
CN104394869A
(zh)
|
2011-10-20 |
2015-03-04 |
葛兰素史密斯克莱有限责任公司 |
用作沉默调节蛋白调节剂的取代的双环氮杂杂环化合物和类似物
|
|
WO2013096060A1
(en)
|
2011-12-23 |
2013-06-27 |
Novartis Ag |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
|
WO2013134079A1
(en)
*
|
2012-03-05 |
2013-09-12 |
Amgen Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
EP2822559B1
(en)
|
2012-03-09 |
2018-05-02 |
Lexicon Pharmaceuticals, Inc. |
Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and uses thereof
|
|
PL2822555T3
(pl)
|
2012-03-09 |
2018-04-30 |
Lexicon Pharmaceuticals Inc |
Inhibicja związanej z adaptorem kinazy-1 dla leczenia bólu
|
|
WO2013148333A1
(en)
|
2012-03-28 |
2013-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Salicylic acid derivatives useful as glucocerebrosidase activators
|
|
BR112014029404A2
(pt)
|
2012-05-31 |
2017-06-27 |
Hoffmann La Roche |
compostos , composição farmacêutica, utilização de um composto, método para o tratamento ou profilaxia do cancêr e invenção
|
|
JP6311603B2
(ja)
|
2012-06-22 |
2018-04-18 |
住友化学株式会社 |
縮合複素環化合物
|
|
WO2014025651A1
(en)
|
2012-08-06 |
2014-02-13 |
Amgen Inc. |
Chroman derivatives as trpm8 inhibitors
|
|
EA201590482A1
(ru)
|
2012-09-05 |
2015-07-30 |
Байер Кропсайенс Аг |
Применение замещенных 2-амидобензимидазолов, 2-амидобензоксазолов и 2-амидобензотиазолов или их солей в качестве биологически активных веществ против абиотического стресса растений
|
|
CA2889919C
(en)
|
2012-11-16 |
2021-08-17 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
US9938258B2
(en)
|
2012-11-29 |
2018-04-10 |
Karyopharm Therapeutics Inc. |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
|
|
DK2941432T3
(en)
*
|
2012-12-07 |
2018-06-14 |
Vertex Pharma |
2-amino-6-fluoro-N- (5-fluoro-4- (4- (4- (oxetan-3-yl) piperazine-1-carbonyl) piperidin-1-yl) pyridine-3-yl) pyrazolo [ 1,5ALPHA] PYRIMIDIN-3-CARBOXAMIDE AS ATR-KINASE INHIBITOR
|
|
KR20140086002A
(ko)
|
2012-12-28 |
2014-07-08 |
한미약품 주식회사 |
Fms 키나아제 저해 활성을 갖는 피리다진 접합고리 유도체
|
|
WO2014141129A2
(en)
|
2013-03-14 |
2014-09-18 |
Grueneberg Dorre A |
Novel methods, compounds, and compositions for inhibition of ros
|
|
EP2970266B1
(en)
|
2013-03-15 |
2018-01-31 |
Epizyme, Inc. |
1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
JPWO2015012328A1
(ja)
|
2013-07-24 |
2017-03-02 |
武田薬品工業株式会社 |
複素環化合物
|
|
WO2015026574A1
(en)
|
2013-08-20 |
2015-02-26 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
|
MX2016002367A
(es)
|
2013-08-23 |
2016-10-28 |
Incyte Corp |
Compuestos de carboxamida de furo y tienopiridina utiles como inhibidores de cinasas pim.
|
|
AR097543A1
(es)
|
2013-09-06 |
2016-03-23 |
Lexicon Pharmaceuticals Inc |
COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
|
|
TW201542550A
(zh)
|
2013-09-06 |
2015-11-16 |
Lexicon Pharmaceuticals Inc |
吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
|
|
WO2015073267A1
(en)
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
ES2687843T3
(es)
|
2014-03-27 |
2018-10-29 |
Academisch Medisch Centrum |
Iminoazúcares N-(5-((aril o heteroril)metiloxi)pentil)-sustituidos como inhibidores de glucosilceramida sintasa
|
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
|
US20170333435A1
(en)
|
2014-11-06 |
2017-11-23 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
|
|
US10570135B2
(en)
|
2014-11-06 |
2020-02-25 |
Lysosomal Therapeutics Inc. |
Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders
|
|
WO2016073891A1
(en)
|
2014-11-06 |
2016-05-12 |
Lysosomal Therapeutics Inc. |
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
|
|
US10167270B2
(en)
|
2015-07-01 |
2019-01-01 |
Northwestern University |
Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity
|
|
WO2017004408A1
(en)
|
2015-07-01 |
2017-01-05 |
Northwestern University |
Substituted 4-methyl-pyrrolo[1.2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
|
|
WO2017040877A1
(en)
|
2015-09-04 |
2017-03-09 |
Lysosomal Therapeutics Inc. |
Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
|
|
MA43169B1
(fr)
|
2015-11-06 |
2022-05-31 |
Incyte Corp |
Composés héterocycliques en tant qu' inhibiteurs pi3k-gamma
|
|
US10479793B2
(en)
|
2015-11-18 |
2019-11-19 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
|
|
WO2017140825A1
(en)
|
2016-02-18 |
2017-08-24 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds, compositions and methods of use thereof
|
|
AU2017246455B2
(en)
|
2016-04-06 |
2021-09-30 |
Bial - R&D Investments, S.A. |
Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
CA3020310A1
(en)
|
2016-04-06 |
2017-10-12 |
Lysosomal Therapeutics Inc. |
Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
US10787454B2
(en)
|
2016-04-06 |
2020-09-29 |
BIAL—BioTech Investments, Inc. |
Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
|
|
WO2017192841A1
(en)
|
2016-05-04 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
AU2017261291C1
(en)
|
2016-05-05 |
2022-05-26 |
Bial - R&D Investments, S.A. |
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders
|
|
EP3452480A4
(en)
|
2016-05-05 |
2019-11-06 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED PYRROLO [1,2-] TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
US11345698B2
(en)
|
2016-05-05 |
2022-05-31 |
Bial—R&D Investments, S.A. |
Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders
|
|
EP3728265A1
(en)
|
2017-12-21 |
2020-10-28 |
BIAL - BioTech Investments, Inc. |
Crystalline substituted cyclohexyl pyrazolo[1,5-a]pyrimidinyl carboxamide compound and therapeutic uses thereof
|
